Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2013783671
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2013783671
Title / Product Name
ZUR BEHANDLUNG VON FRAGILEM X SYNDROM, PARKINSONSCHER ODER REFLUXKRANKHEIT GEEIGNETE DIAZEPINON DERIVATE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2013783671
EP Publication Number
2888259
E-Number
976427
Language
EN
PCT Number
IB13056782
Publication Date
01.07.2015 A
07.03.2018 B1
Registration Date
07.03.2018
AT Publication Date
15.03.2018
Application Date
21.08.2013
Registration Number
-
Priorities
23.08.2012
GB
201215033
IPC
C07D 471/04 20060101AFI20140311BHEP
Maximum Duration of Protection
21.08.2033
Owner
Novartis AG
Lichtstrasse 35
4056 Basel
CH
Representative
Representative
SCHWARZ & PARTNER PATENTANWÄLTE OG
Wipplingerstraße 30
1010 Wien
AT
Inventor
BEHNKE, Dirk
Novartis Pharma AG Werk Klybeck Postfach
CH-4002 Basel
CH
CARCACHE, David
Novartis Pharma AG Postfach
CH-4002 Basel
CH
ERTL, Peter
Novartis Pharma AG Postfach
CH-4002 Basel
CH
KOLLER, Manuel
Novartis Pharma AG Postfach
CH-4002 Basel
CH
ORAIN, David
Novartis Pharma AG Postfach
CH-4002 Basel
CH